- oesophageal/gastric cancer
- hepatobiliary (including pancreatic)
- neuroendocrine tumours
- colorectal cancer
- clinical trials of novel therapeutics in gastrointestinal cancers
Dr Naureen Starling is a Consultant Medical Oncologist at The Royal Marsden specialising in the treatment of gastrointestinal (GI) cancers and an Honorary Clinical Senior Lecturer within the Division of Clinical Studies at the Institute of Cancer Research.
Dr Starling graduated from University College London with First Class Honours in Physiology (BSc) and distinctions in Clinical Pharmacology/Therapeutics and Pathology. She undertook general medical training at University College Hospital and Northwick Park/St Marks’s hospitals and specialist training in Medical Oncology at The Royal Marsden. Her postgraduate degree at the ICR focused on the genomics and therapeutics of oesophageal cancer.
Her research interests in GI cancers (oesophageal, gastric, pancreatic, neuroendocrine and colorectal) are focussed on earlier phase clinical trials, novel therapeutics and the delivery of individualised medicine to patients with gastrointestinal cancers. She is the principal investigator on numerous international clinical trials of novel drugs in oesophago-gastric, pancreatic and colorectal cancer. She is a member of several multi-centre clinical trial steering and safety review committees. Dr Starling has been a lead or co-applicant on a number of successful peer-reviewed research grant applications.
She is the Associate Director of Clinical Research and Clinical Lead for the Royal Marsden’s West Wing Clinical Research Centre. She is the Upper GI Lead for the South London Cancer Research Network, and serves on the UK National Cancer Research Institute oesophago-gastric sub-group. She has acted as a clinical expert in oesophago-gastric cancer for NICE (guideline committee and technology appraisal) and is a clinical expert for Pancreatic Cancer UK. She is a member of the EORTC General Assembly representing The Royal Marsden.
Dr Starling also holds educational roles including the NIHR Training Lead for the RM/Institute of Cancer Research Biomedical Research Centre, member of the ICR/Imperial College CRUK Major centre training committee, Deputy Training Program Director (one of three) for South London Medical Oncology Training, member of the pan-London specialist Medical oncology training committee and member of the Medical Oncology National Recruitment steering committee.